Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	88.43	-110.71	-956.71
Graham Fair Price	160.05	5.84	2.24
PEG	-97.95	0.04	-1.84
Price/Book	12.91	11.38	10.08
Price/Cash Flow	-84.67	91.25	595.19
Prices/Earnings	-86.00	-31.79	227.12
Price/Sales	40.97	45.15	32.03
Price/FCF	-84.67	91.25	595.19
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-7.05	0.81	0.87
Operating Margin	-1211.18	-0.45	-0.03
ROA	680.81	-0.04	< 0.005
ROE	0.01	-0.09	706.71
ROIC	-0.19	-0.07	60.72
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.03	-73.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.82	-8.70	961.08
EPS QOQ	1.24	-8.43	581.39
FCF QOQ	0.38	5.80	1410.52
Revenue QOQ	0.26	-0.26	0.06
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-303.33	0.00	inf
Days Sales Outstanding (DSO)	107.77	79.28	-26.43
Inventory Turnover	-0.30	0.00	inf
Debt/Capitalization	0.39	0.37	-5.97
Quick Ratio	2.34	2.18	-6.79
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.49	4.11	-8.44
Cash	4.90	4.98	1.77
Capex	-0.02	< 0.005	86.33
Free Cash Flow	0.08	0.51	574.33
Revenue	1.41	1.04	-26.67
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.50	2.38	-4.77
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-15.47	-3.38	78.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating